Patents by Inventor Virginia A. HAURIGOT-MENDONÇA

Virginia A. HAURIGOT-MENDONÇA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
    Patent number: 11338046
    Abstract: The present invention provides new adeno-associated virus-derived vectors and pharmaceutical compositions containing the same for the treatment of lysosomal storage disorders and specially, for the treatment of mucopolysaccharidoses Type IIID.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: May 24, 2022
    Assignees: ESTEVE PHARMACEUTICALS, S.A., UNIVERSITAT AUTÓNOMA DE BARCELONA
    Inventors: Carles Roca Lecha, Virginia A. Haurigot-Mendonça, Fàtima Bosch Tubert
  • Single-vector gene construct comprising insulin and glucokinase genes
    Patent number: 11033638
    Abstract: The invention relates to a viral expression construct and related viral vector and composition and to their use wherein the construct and vector comprise elements a) and b): a) a nucleotide sequence encoding an insulin operably linked to a first promoter, b) a nucleotide sequence encoding a glucokinase operably linked to a second promoter and the viral expression construct and related viral vector comprise at least one of elements c), d) and e): c) the first and the second promoters are positioned in reverse orientation within the expression construct, d) the first and the second promoters are positioned in reverse orientation within the expression construct and are located adjacent to each other and e) the first promoter is a CMV promoter, preferably a mini CMV promoter.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: June 15, 2021
    Assignee: UNIVERSITÄT AUTONOMA DE BARCELONA
    Inventors: Fatima Bosch Tubert, Miguel Garcia Martinez, Veronica Jiménez Cenzano, Virginia Haurigot Mendonça
  • ADENOASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSES
    Publication number: 20190231900
    Abstract: The present invention provides new adeno-associated virus-derived vectors and pharmaceutical compositions containing the same for the treatment of lysosomal storage disorders and specially, for the treatment of mucopolysaccharidoses Type IIID.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 1, 2019
    Inventors: Carles ROCA LECHA, Virginia A. HAURIGOT-MENDONÇA, Fàtima BOSCH TUBERT